• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和非肥胖多囊卵巢综合征女性体内的巨噬细胞移动抑制因子

Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.

作者信息

Mejia-Montilla Jorly, Álvarez-Mon Melchor, Reyna-Villasmil Eduardo, Torres-Cepeda Duly, Santos-Bolívar Joel, Reyna-Villasmil Nadia, Suarez-Torres Ismael, Bravo-Henríquez Alfonso

机构信息

Servicio de Ginecología, Hospital Central Dr. Urquinaona, Maracaibo, Estado Zulia, Venezuela.

Departamento de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España.

出版信息

Endocrinol Nutr. 2015 Jan;62(1):31-7. doi: 10.1016/j.endonu.2014.09.005. Epub 2014 Nov 15.

DOI:10.1016/j.endonu.2014.09.005
PMID:25458401
Abstract

OBJECTIVE

To measure macrophage migration inhibitory factor (MIF) concentrations in obese and non-obese women diagnosed with polycystic ovary syndrome (PCOS).

METHODS

Women diagnosed with PCOS and age-matched healthy controls with regular menses and normal ovaries on ultrasound examination were selected and divided into 4 groups (group A, PCOS and obese; group B, PCOS and non-obese; group C, obese controls; and group D, non-obese controls) based on body mass index (obese >30 kg/m2 and non-obese <25 kg/m2). Luteinizing hormone, follicle-stimulating hormone, androstenedione, testosterone, sex hormone-binding globulin, serum glucose, insulin and MIF levels were measured.

RESULTS

Obese and non-obese women with PCOS had higher luteinizing hormone, follicle-stimulating hormone, androstenedione, testosterone, and insulin levels as compared to the obese and non-obese control groups, respectively (P < .0001). Women with PCOS had significantly higher MIF levels (group A, 48.6 ± 9.9 mg/ml; group B, 35.2 ± 6.0 ng/ml) as compared to controls (group C, 13.5 ± 6.0 ng/ml; group D, 12.0 ± 4.3 ng/dl; P < .0001). A weak, positive and significant correlation was seen between fasting blood glucose and insulin levels in women with PCOS (P < .05).

CONCLUSION

Significant differences exist in plasma MIF levels between obese and non-obese women with and without PCOS.

摘要

目的

测量诊断为多囊卵巢综合征(PCOS)的肥胖和非肥胖女性体内巨噬细胞移动抑制因子(MIF)的浓度。

方法

选取诊断为PCOS的女性以及年龄匹配的月经规律且超声检查卵巢正常的健康对照者,根据体重指数(肥胖>30 kg/m²,非肥胖<25 kg/m²)分为4组(A组,PCOS且肥胖;B组,PCOS且非肥胖;C组,肥胖对照;D组,非肥胖对照)。测量促黄体生成素、促卵泡生成素、雄烯二酮、睾酮、性激素结合球蛋白、血糖、胰岛素和MIF水平。

结果

与肥胖和非肥胖对照组相比,患有PCOS的肥胖和非肥胖女性的促黄体生成素、促卵泡生成素、雄烯二酮、睾酮和胰岛素水平分别更高(P <.0001)。与对照组相比,患有PCOS的女性的MIF水平显著更高(A组,48.6±9.9 mg/ml;B组,35.2±6.0 ng/ml)(C组,13.5±6.0 ng/ml;D组,12.0±4.3 ng/dl;P <.0001)。PCOS女性的空腹血糖与胰岛素水平之间存在微弱、正性且显著的相关性(P <.05)。

结论

患有和未患有PCOS的肥胖和非肥胖女性之间血浆MIF水平存在显著差异。

相似文献

1
Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.肥胖和非肥胖多囊卵巢综合征女性体内的巨噬细胞移动抑制因子
Endocrinol Nutr. 2015 Jan;62(1):31-7. doi: 10.1016/j.endonu.2014.09.005. Epub 2014 Nov 15.
2
[Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
Endocrinol Nutr. 2012 Jan;59(1):21-7. doi: 10.1016/j.endonu.2011.09.003. Epub 2011 Nov 23.
3
A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome.多囊卵巢综合征中促黄体生成素与巨噬细胞移动抑制因子水平之间的潜在联系。
Endocr Res. 2016 Aug;41(3):261-9. doi: 10.3109/07435800.2015.1135442. Epub 2016 Feb 25.
4
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.多囊卵巢综合征和肥胖对绝经前女性血清促性腺激素和性激素浓度的独立影响。
Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81. doi: 10.1111/j.1365-2265.1994.tb02578.x.
5
[Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].[无其他疾病的肥胖女性和多囊卵巢综合征患者的胰岛素抵抗以及卵巢和肾上腺雄激素的血清浓度]
Endokrynol Pol. 2005 Nov-Dec;56(6):921-6.
6
Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.多囊卵巢综合征女性体内的神经肽Y、瘦素、甘丙肽和胰岛素。
Gynecol Endocrinol. 1999 Oct;13(5):344-51. doi: 10.3109/09513599909167578.
7
The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.非肥胖型多囊卵巢综合征患者血浆网膜素-1与胰岛素抵抗的相关性
Ann Endocrinol (Paris). 2015 Oct;76(5):620-7. doi: 10.1016/j.ando.2015.08.002. Epub 2015 Oct 26.
8
Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.肥胖和非肥胖多囊卵巢综合征患者血清中卵泡抑素和激活素A的浓度
Hum Reprod. 2001 Dec;16(12):2552-6. doi: 10.1093/humrep/16.12.2552.
9
Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.多囊卵巢综合征患者中与激素和代谢谱相关的metastin水平
Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:56-60. doi: 10.1016/j.ejogrb.2014.06.004. Epub 2014 Jun 13.
10
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.多囊卵巢综合征的瘦型和肥胖型女性的胰岛素、生长激素及促黄体生成素轴:共同特征与不同特征
J Clin Endocrinol Metab. 1996 Aug;81(8):2854-64. doi: 10.1210/jcem.81.8.8768842.

引用本文的文献

1
The role of macrophages in polycystic ovary syndrome: A review.巨噬细胞在多囊卵巢综合征中的作用:综述
Medicine (Baltimore). 2025 Apr 25;104(17):e42228. doi: 10.1097/MD.0000000000042228.
2
Pathophysiological Role of Genetic Factors Associated With Gestational Diabetes Mellitus.与妊娠期糖尿病相关的遗传因素的病理生理作用
Front Physiol. 2022 Apr 4;13:769924. doi: 10.3389/fphys.2022.769924. eCollection 2022.
3
MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.MIF 可能通过 MAPK 信号通路参与多囊卵巢综合征大鼠的发病机制。
Curr Med Sci. 2018 Oct;38(5):853-860. doi: 10.1007/s11596-018-1953-7. Epub 2018 Oct 20.
4
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.巨噬细胞移动抑制因子在肥胖、胰岛素抵抗、2型糖尿病及相关肝脏合并症中的作用:对人类和啮齿动物研究的综合综述
Front Immunol. 2015 Jun 15;6:308. doi: 10.3389/fimmu.2015.00308. eCollection 2015.